120 filings
Page 3 of 6
8-K
gibxjsb
30 Nov 09
Other Events
12:00am
8-K
7btmlma c8srt8unu1s6
2 Nov 09
Human Genome Sciences Announces Third Quarter 2009 Financial Results and Key Developments
12:00am
8-K
vani13kp86j
3 Aug 09
Human Genome Sciences Announces Pricing of Public Offering of Common Stock
12:00am
8-K
7eu7kpwv48
27 Jul 09
Other Events
12:00am
8-K
tjgwgdjp3ju9bsrwfipq
23 Jul 09
Human Genome Sciences Announces New Order for Raxibacumab (Abthrax™) from U.s. Government
12:00am
8-K
4vjpqe8wo 8rxolb4n
29 Apr 09
Human Genome Sciences Announces First Quarter 2009 Financial Results and Key Developments
12:00am
8-K
6h67n80n
26 Feb 09
Human Genome Sciences Announces Fourth-quarter and Full-year 2008 Financial Results and Key Developments
12:00am
8-K
9iupyp
12 Jan 09
Results of Operations and Financial Condition
12:00am
8-K
cwvpg xaw
6 Nov 08
Human Genome Sciences Announces Third Quarter 2008 Financial Results and Key Developments
12:00am
8-K
j93gko qypx0aq
30 Jul 08
Human Genome Sciences Announces Second Quarter 2008 Financial Results and Key Developments
12:00am
8-K
j3xe1r 1qg7wwu78
28 Jul 08
Human Genome Sciences Appoints David P. Southwell to Its Board of Directors
12:00am
8-K
v8ev3mbjtxe9qvi5orcb
8 May 08
Human Genome Sciences Appoints John L. Lamattina, PH.D., to Its Board of Directors
12:00am
8-K
eyl5f7t 1rjpyr
5 May 08
Human Genome Sciences Announces First Quarter 2008 Financial Results and Key Developments
12:00am
8-K
i8s51u
25 Feb 08
Human Genome Sciences Announces Fourth Quarter and Full Year 2007 Financial Results and Recent Progress
12:00am
8-K
g0mw3t 1c7rpqt9u
21 Feb 08
Human Genome Sciences Appoints Maxine Gowen, PH.D., to Its Board of Directors
12:00am
8-K
cmnxv xx5
7 Jan 08
Human Genome Sciences Announces 2008 Goals and Reports Substantial Progress Toward Commercialization at Jpmorgan Healthcare Conference
12:00am
8-K
fmb 5wfbx
20 Dec 07
Human Genome Sciences and Aegera Therapeutics Announce Licensing and Collaboration Agreement on Novel Anti-cancer Drugs
12:00am
8-K
p4ff5zj urs0tg
20 Dec 07
Departure of Directors or Principal Officers
12:00am
8-K
aiu20i
1 Nov 07
Human Genome Sciences Announces Third Quarter 2007 Financial Results and Key Developments
12:00am
8-K
ynqp 88iepz
31 Aug 07
Departure of Directors or Principal Officers
12:00am